Skip to content
healthcare.dev

NovoLog Mix 70/30

NDC 0169-3685, insulin aspart, injection, suspension, from Novo Nordisk Pharmaceutical Industries, LP.

Product NDC
0169-3685
Status
Listed
Labeler
Novo Nordisk Pharmaceutical Industries, LP
Dosage form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA021172
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0169-3685 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN ASPART100 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
0169-3685-12001693685121 VIAL, GLASS in 1 CARTON (0169-3685-12) / 10 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1861fcee-7673-4afe-a206-08fa05c0add2
  • NADAC price for package 00169368512

    GET /v1/drugs/nadac/00169368512

Use it

Look up 0169-3685 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0169-3685 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0169-3685. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.